Provided by Tiger Trade Technology Pte. Ltd.

Weight Loss Drugs

1,613.96
+15.890.99%
Number of Gainers:6
Number of Losers:1
Number of Flat:- -
PE:- -
High:1,616.03
Open:1,597.73
Low:1,578.30
Close:1,598.08
Volume:44.14M
Turnover:3.87B
Market Cap:1.68T
Float Cap:1.62T

Loading ...

Pfizer Inc. Stock Underperforms Friday When Compared to Competitors Despite Daily Gains

Dow Jones
·
4 hours ago

Amgen Inc. Stock Underperforms Friday When Compared to Competitors Despite Daily Gains

Dow Jones
·
4 hours ago

Pfizer’s New RSV Vaccine Trial Targets Older Adults, Signaling Long-Term Growth Potential

TIPRANKS
·
8 hours ago

Pfizer’s New Asthma Bet: Tilrekimig Phase 3 Trial Moves Forward

TIPRANKS
·
8 hours ago

Novo Nordisk price target lowered to DKK 296 from DKK 310 at Citi

TIPRANKS
·
8 hours ago

Novo Nordisk A/S Series B Stock Rises Friday, Outperforms Market

Dow Jones
·
9 hours ago

5%, Really? the Stock Market's Sudden High-Yielders.

Dow Jones
·
Yesterday

1 Drugs Could Ease Back and Knee Pain, but Doctors Say There are Risks for Older Adults

Dow Jones
·
Yesterday

BofA Securities Adjusts Pfizer Price Target to $29 From $27, Maintains Neutral Rating

MT Newswires Live
·
Yesterday

BofA Securities Adjusts Eli Lilly Price Target to $1,341 From $1,344, Maintains Buy Rating

MT Newswires Live
·
Yesterday

J.P. Morgan Keeps Their Hold Rating on Pfizer (PFE)

TIPRANKS
·
Yesterday

An AI Transformation That Finally Let Pfizer CEO Albert Bourla Sleep Soundly

Deep News
·
Yesterday

Pfizer Limited Confirms SEBI Compliance on Share Dematerialization for Q3 2026

TIPRANKS
·
Yesterday

Analysts Have Conflicting Sentiments on These Healthcare Companies: Envista Holdings (NVST), Bristol-Myers Squibb (BMY) and Eli Lilly & Co (LLY)

TIPRANKS
·
Yesterday

Eli Lilly announces new TOGETHER-PsO trial data

TIPRANKS
·
Yesterday

Pfizer price target raised to $29 from $27 at BofA

TIPRANKS
·
Yesterday

Lilly Says Phase 3b Together-PsO Data Show Broader Biomarker Shifts with Taltz Plus Zepbound vs Taltz Alone

Reuters
·
Yesterday

Eli Lilly price target lowered to $1,341 from $1,344 at BofA

TIPRANKS
·
Yesterday

Eli Lilly - Taltz and Zepbound Together Show Greater Reductions in Inflammatory Immune Activity

THOMSON REUTERS
·
Yesterday

Eli Lilly: Improvements were Maintained or Further Improved Through Week 52, with Safety Consistent with Known Profile of Each Respective Medicine

THOMSON REUTERS
·
Yesterday